Altered interplay between endoplasmic reticulum and mitochondria in Charcot–Marie–Tooth type 2A neuropathy

Nathalie Bernard‐Marissal(Inserm), Gerben van Hameren(Inserm), Manisha Juneja(University of Antwerp), Christophe Pellegrino(Inserm), Lauri Louhivuori(Karolinska Institutet), Luca Bartesaghi(Stockholm University), Cylia Rochat(École Polytechnique Fédérale de Lausanne), Omar El Mansour(École Polytechnique Fédérale de Lausanne), Jean‐Jacques Médard(Stockholm University), Marie Croisier(École Polytechnique Fédérale de Lausanne), Catherine Maclachlan(École Polytechnique Fédérale de Lausanne), Olivier Poirot(University Hospital of Lausanne), Per Uhlén(Karolinska Institutet), Vincent Timmerman(University of Antwerp), Nicolas Tricaud(Inserm), Bernard L. Schneider(École Polytechnique Fédérale de Lausanne), Roman Chrast(Stockholm University)
Proceedings of the National Academy of Sciences
January 18, 2019
Cited by 99Open Access
Full Text

Abstract

induces distal axonal degeneration in the absence of overt neuronal death. The presence of mutant protein leads to reduction in endoplasmic reticulum and mitochondria contacts in CMT2A patient-derived fibroblasts, in primary neurons and in vivo, in motoneurons of a mouse model of CMT2A. These changes are concomitant with endoplasmic reticulum stress, calcium handling defects, and changes in the geometry and axonal transport of mitochondria. Importantly, pharmacological treatments reinforcing endoplasmic reticulum-mitochondria cross-talk, or reducing endoplasmic reticulum stress, restore the mitochondria morphology and prevent axonal degeneration. These results highlight defects in MAM as a cellular mechanism contributing to CMT2A pathology mediated by mutated MFN2.


Related Papers

No related papers found

Powered by citation graph analysis